Implanon Contraceptive Implants Do Not Induce Abortion – FDA

The Food and Drug Administration (FDA) has certified that contraceptive implant brands Implanon and Implanon NXT are non-abortifacients or do not cause abortion.

The FDA on Sunday, November 12, released the results of its re-certification process of all 51 contraceptives covered by the two-year-old temporary restraining order (TRO) issued by the Supreme Court (SC) against the Reproductive Health (RH) Law. The document was dated Friday, November 10.

“Per the FDA’s Resolutions dated 10 November 2017 (on the applications for recertification filed by the Market Authorization Holders [MAHs] with opposition filed by Alliance for the Family Foundation, Philippines, Inc. [ALFI]), the foregoing contraceptive products have been determined to be non-abortifacient,” the FDA advisory read.

The resolution of the FDA, which began its review process in late August, signals the imminent lifting of the SC TRO. This is because the High Court had ruled in 2015 that the TRO would be deemed lifted if, after compliance with due process, the “questioned drugs and devices are found not abortifacient” by the FDA.